Stellantis: Recovery Deferred, Near-Term Challenges Widen

  • Stellantis' H1 2025 results disappointed, with sales down 13% and negative €3 billion in free cash flow. Key positives like inventory management and cash generation have reversed with guidance reinstated, but at the low end of expectations. We cut our 2025 forecasts, see no dividend in 2026, and move to a Neutral rating.